Entries by Andrew Humphreys

, , , , , ,

POCN and HealthSTAR Communications Partner to Offer NPs and PAs Peer-to-Peer Educational Series Across the U.S.

POCN, the largest Nurse Practitioner (NP) and Physician Associate (PA) network in the United States, and HealthSTAR Communications, an integrated omni-channel agency network uniquely positioned to deliver cutting-edge proprietary technology and capabilities to healthcare professionals and patients, partnered to bring POCN’s best-in-class Live Local peer-to-peer educational series focused on NPs and PAs.

, , , ,

Klick Health partners with The Vaccine Confidence Project and YouTube on new COVID vaccine video series aimed at Gen Z + Millennials

Alien babies? Scary ingredients? Gen Z and Millennials are being inundated with misinformation around COVID vaccination. Klick Health and The Vaccine Confidence Project at the London School of Hygiene and Tropical Medicine (VCP) are trying to change that by reaching 18-30 year olds on a platform they use regularly: YouTube.

, , , , , , ,

Decentralized Clinical Trials Are Here to Stay

The popularity of decentralized clinical trials (DCTs) is surging, especially among patients. Harnessing technology of all kinds, these trials provide an attractive alternative to the old-style, site-anchored system on which traditional clinical trials have rested. They also have the potential to provide better, more timely data since that data is primarily collected under real-life situations and often available more quickly to monitoring teams, according to Kristin Mauri, Director of Solution Services, Remarque Systems.

, , , , , , , ,

It’s Time for a Collaborative Approach to Gene Therapy Reimbursement

With more than 1,000 clinical trials for cell and gene therapies in process and predictions that such products will generate $12 billion in revenue annually by 2025, leaders for pharmaceutical companies and health plans must consider how to make gene therapies financially accessible to those who need them. According to Cotiviti Executive Vice President of Operations Jordan Bazinsky, this is an opportunity to explore a new paradigm for reimbursement for complex therapies—one that is informed by collaborative partnership, with careful consideration of the best way to pay for value.